Long-acting beta-agonists and the risk of intensive care unit admission in children.

about

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies Orally inhaled fixed-dose combination products for the treatment of asthma and chronic obstructive pulmonary disease: not simple math.

P2860

Q27027449-B3D850C2-016C-45C4-B256-AEB7D4226C5A Q38193172-198F33B3-9A99-4510-890B-28B18BA89D11

P2860

Long-acting beta-agonists and the risk of intensive care unit admission in children.

Item

http://www.wikidata.org/entity/Q36912259

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Long-acting beta-agonists and the risk of intensive care unit admission in children.

@en

type

Item

label

Long-acting beta-agonists and the risk of intensive care unit admission in children.

@en

prefLabel

Long-acting beta-agonists and the risk of intensive care unit admission in children.

@en

P1476

Long-acting beta-agonists and the risk of intensive care unit admission in children

@en

P2093

Andrew J MacGinnitie

http://www.w3.org/2001/XMLSchema#string

Bobby L Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Regular treatment with salmeterol for chronic asthma: serious adverse events

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007

Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials.

The safety of long-acting beta-agonists: more evidence is needed.

Serious asthma exacerbations in asthmatics treated with high-dose formoterol.

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.

Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.

P304

450-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02770903.2012.677894

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tammy S Jacobs

P577

2012-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224864744

http://www.w3.org/2001/XMLSchema#string

P698

22540879

http://www.w3.org/2001/XMLSchema#string

P921

intensive care unit

P932

3676306

http://www.w3.org/2001/XMLSchema#string

Long-acting beta-agonists and the risk of intensive care unit admission in children.

about

P2860

P2860

Long-acting beta-agonists and the risk of intensive care unit admission in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932